Sawhney Simon, Djurdjev Ognjenka, Simpson Keith, Macleod Alison, Levin Adeera
University of Aberdeen, Aberdeen, UK.
Nephrol Dial Transplant. 2009 Oct;24(10):3186-92. doi: 10.1093/ndt/gfp189. Epub 2009 Apr 23.
Outcomes are a major metric for evaluating effectiveness of dialysis. Comparisons between different populations reveal significant variation. In addition, the question of optimal timing of dialysis start lacks robust data from which to generate conclusions.
This study compares dialysis survival in two geographically similar areas, Scotland and British Columbia, Canada (BC). The effect of eGFR at dialysis start on survival was also measured. Incident adult dialysis populations of Scotland (n = 3372) and BC (n = 3927), 2000-05 were compared. Mortality Hazard ratios (HR) were calculated using a Cox proportional hazards model. Multivariate analysis included pre-dialysis eGFR, registry, age, sex, dialysis modality, year of start, pre-dialysis haemoglobin and primary renal diagnosis.
Median survival times from start of dialysis were 38 (35-40) and 44 (42-47) months in Scotland and BC, respectively, giving an unadjusted mortality HR, Scotland versus BC, of 1.20 (95% C.I. 1.12-1.29). BC patients started dialysis at a higher eGFR (8.9 ml/min/1.73 m(2)) than Scotland (7.5 ml/min/1.73 m(2)), and prior to modelling higher starting eGFR was associated with higher mortality (1 ml/min/1.73 m(2) increase, HR = 1.028; 95% C.I. 1.021-1.035). BC patients were also older and had more diabetic renal disease. In multivariate analysis, lower starting eGFR was associated with better survival, and Scotland had greater mortality than BC. General population mortality and transplantation rate had only minor influence.
Concepts of 'late' versus 'early' start dialysis based on eGFR alone may need modification given the complexity and confounding reasons for dialysis initiation.
治疗结果是评估透析疗效的主要指标。不同人群之间的比较显示出显著差异。此外,关于开始透析的最佳时机问题缺乏有力数据来得出结论。
本研究比较了两个地理上相似地区——苏格兰和加拿大不列颠哥伦比亚省(BC)——的透析患者生存率。还测量了开始透析时估算肾小球滤过率(eGFR)对生存率的影响。对2000 - 2005年苏格兰(n = 3372)和BC(n = 3927)的成年新发透析人群进行了比较。使用Cox比例风险模型计算死亡风险比(HR)。多变量分析包括透析前eGFR、登记处、年龄、性别、透析方式、开始年份、透析前血红蛋白和原发性肾脏诊断。
苏格兰和BC开始透析后的中位生存时间分别为38(35 - 40)个月和44(42 - 47)个月,苏格兰与BC的未调整死亡HR为1.20(95%置信区间1.12 - 1.29)。BC患者开始透析时的eGFR(8.9 ml/min/1.73 m²)高于苏格兰(7.5 ml/min/1.73 m²),在进行模型分析之前,较高的起始eGFR与较高死亡率相关(每增加1 ml/min/1.73 m²,HR = 1.028;95%置信区间1.021 - 1.035)。BC患者年龄也更大,糖尿病肾病患者更多。在多变量分析中,较低的起始eGFR与更好的生存率相关,且苏格兰的死亡率高于BC。一般人群死亡率和移植率的影响较小。
鉴于透析开始的复杂性和混杂因素,仅基于eGFR的“晚”或“早”开始透析的概念可能需要修正。